Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Apple Inc. reported record fiscal Q1 earnings, but growth was modest and shares remain expensive despite recent pullback.

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

Gross domestic product (GDP) increased at an annual rate of 2.3% in the fourth quarter of 2024, according to the Bureau of ...

IBM's stock price jump on 30th January was the biggest one-day percentage gain ever recorded in the company's history on the ...

CNBC Select reviews Bank of America mortgage offerings, including purchase loans, refinancing, closing cost grants and more.

Microsoft is the worst Dow Jones stock Thursday as the tech giant's soft outlook offsets an earnings beat. Here's what you need to know.

Invest in Nvidia Corporation as AI spending surges. Recent dip offers a buying opportunity. Read my in-depth look at NVDA ...

Regular MarketWatch readers might already be aware that U.S. stocks are historically expensive right now, based on several popular metrics. Some have argued that this could signal that the market has ...

Investors need to pay close attention to TELUS (TU) stock based on the movements in the options market lately.

U.S. stock futures point mostly higher as investors react to corporate earnings, Apple is slated to report results after the ...

Tech stocks, notably those related to artificial intelligence, slumped on Monday after the DeepSeek grey swan event. Dr James ...